Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer.

NCT05331833 · clinicaltrials.gov ↗

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Stage III Non-small-cell Lung Cancer

Interventions

RADIATION: The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.

Sponsor

Jianguo Sun